Garrett Mary 4

What Happened
Mary Garrett, a director of PROCEPT BioRobotics Corp. (PRCT), received equity awards on June 9, 2026: 3,315 restricted stock units (RSUs) and 5,853 derivative awards (reported as a stock option). Both grants show a $0.00 acquisition price; total awards equal 9,168 units. These are compensation grants (not open‑market purchases or sales).

Key Details

• Transaction date: 2026-06-09; filing date: 2026-06-10 (filed the next day).
• Reported price: $0.00 for both the RSUs and the derivative award.
• Award breakdown: 3,315 RSUs (each convertible to one share) and 5,853 derivative awards (described as a stock option in the filing).
• Vesting: Both awards vest in full on the earlier of (i) the one‑year anniversary of the grant or (ii) the next annual meeting following the grant, subject to continued service (per footnotes).
• Shares owned after transaction: not specified in the provided Form 4 data.
• Filing timeliness: appears timely (filed the day after the grant).

Context
RSUs are a contingent right to receive common stock only after vesting; the derivative award is reported as a stock option and likewise vests under the same one‑year/next‑meeting schedule. These grants are routine compensation for a director and do not represent an open‑market purchase or sale—no immediate cash exchange or change in share count occurs until vesting or option exercise.